Recursion director sells 40,000 shares under plan
RECURSION PHARMACEUTICALS director Christopher Gibson converted and sold shares in a planned set of transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
RECURSION PHARMACEUTICALS director Christopher Gibson converted and sold shares in a planned set of transactions. On May 22, 2026, he converted 40,000 shares of Class B Common Stock into 40,000 shares of Class A Common Stock, then sold those 40,000 Class A shares in an open-market transaction at $3.08 per share. The filing notes the activity was carried out under a Rule 10b5-1 trading plan adopted on May 12, 2025, indicating the trades were pre-scheduled. After these moves, he directly holds 883,735 Class A shares and 4,303,334 Class B shares, with each Class B share convertible into one Class A share.
Insider Trade Summary 10b5-1
Exercise and Sale: 40,000 shares ($123K approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
Gibson Christopher
Role
Director
Sold
40,000 shs ($123K)
Approx. gross sale proceeds
$123K
Approx. exercise cost
$0.00
Approx. pre-tax spread
$123K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 40,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 40,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 40,000 | $3.08 | $123K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 4,303,334 contracts (Direct);
Class A Common Stock — 883,735 shares (Direct);
Class B Common Stock — 0 contracts (Indirect, by LAHWRAN-3 LLC);
Class B Common Stock — 0 contracts (Indirect, by LAHWRAN-4 LLC);
Class B Common Stock — 0 contracts (Indirect, by Gibson Family Trust);
Stock Option (Right to Buy) — 0 contracts (Direct)
Footnotes (11)
- F1. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
- F2. Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock.
- F3. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- F4. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- F5. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- F6. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- F7. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F8. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F9. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F10. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F11. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Key Figures
Shares sold: 40,000 shares
Sale price: $3.08 per share
Class A holdings after sale: 883,735 shares
+3 more
6 metrics
Shares sold
40,000 shares
Class A Common Stock sold on May 22, 2026
Sale price
$3.08 per share
Average price for 40,000 Class A shares sold
Class A holdings after sale
883,735 shares
Direct Class A Common Stock position after transactions
Class B holdings after conversion
4,303,334 shares
Direct Class B Common Stock after converting 40,000 shares
Converted shares
40,000 shares
Class B Common Stock converted into Class A Common Stock
Lowest option exercise price
$2.48 per share
Stock option on Class A Common Stock expiring December 30, 2030
Key Terms
Rule 10b5-1 trading plan, Class B Common Stock, derivative conversion, Stock Option (Right to Buy, +1 more
5 terms
Rule 10b5-1 trading plan financial
"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class B Common Stock financial
"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
derivative conversion financial
"transaction_action": "derivative conversion""
Stock Option (Right to Buy financial
"security_title": "Stock Option (Right to Buy)""
automatic conversion financial
"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did RXRX director Christopher Gibson report?
Gibson reported converting 40,000 Class B shares into 40,000 Class A shares, then selling 40,000 Class A shares at $3.08 each. These actions are recorded as a derivative conversion followed by an open-market sale on May 22, 2026.
How large was Christopher Gibson’s RXRX stock sale in dollar terms?
Gibson sold 40,000 shares of Class A Common Stock at an average price of $3.08 per share. That implies total sale proceeds of roughly $123,200, based solely on the reported average transaction price and share count.
Does Christopher Gibson still have derivative or option positions tied to RXRX?
Yes. The filing lists several stock options (rights to buy Class A shares) with exercise prices ranging from $2.48 to $11.40 and expiration dates between 2030 and 2035, indicating ongoing derivative-based exposure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates